MBIO — MindBio Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$3.53m
- CA$7.86m
Annual balance sheet for MindBio Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 0.48 | 1.35 | 0.334 | 0.139 |
| Net Total Receivables | 0.001 | 0.046 | 0.054 | 0.055 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.481 | 1.7 | 0.673 | 0.194 |
| Total Assets | 0.481 | 1.7 | 0.673 | 0.194 |
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.957 | 0.994 | 2.93 | 5.63 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.957 | 5.9 | 6.03 | 5.89 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -0.476 | -4.19 | -5.36 | -5.69 |
| Total Liabilities & Shareholders' Equity | 0.481 | 1.7 | 0.673 | 0.194 |
| Total Common Shares Outstanding |